Reports
Reports
Sale
The global non-rebreathing oxygen mask market is expected to grow at a CAGR of 9.2% during the forecast period of 2024-2032, driven by increasing incidence of respiratory diseases across the globe.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A non-rebreathing oxygen mask is a medical device used to assist the delivery of oxygen therapy. Unlike a low-flow nasal cannula, a non-rebreathing oxygen mask allows the delivery of higher concentrations of oxygen. These masks are essential in emergency situations, pre- and post-operative care, and for patients with severe respiratory conditions. According to Centers for Disease Control and Prevention, 4.6 % of adults were diagnosed with COPD, emphysema, or chronic bronchitis by 2022. Increased indulgence in substances like tobacco plays a vital role in deteriorating respiratory health. According to World Health Organization, tobacco smoking accounts for over 70 % of COPD cases in high-income countries. In addition, sudden COVID-19 outbreak also propelled the demand for non-rebreathing oxygen masks.
Increasing Research and Development Activities to Affect the Market Landscape Significantly
With rising incidence of respiratory diseases, the market has been witnessing research on products to analyze the impact of masks on oxygen concentration in disease patients. In May 2020, an interventional clinical study was conducted to compare the effects of two oxygen delivery systems on arterial blood gases, including non-rebreather mask versus double-trunk mask. The study involved 25 participants with acute severe hypoxemia. The study included to observe changes in PaO2 (Oxygen tension), changes in PaCO2 (carbon dioxide tension), and changes in respiratory rate.
Technological Advancements to Meet Rising Non-Rebreathing Oxygen Mask Market Demand
Non-rebreathing oxygen masks are undergoing several technical advancements to provide better and more effective solutions to the consumers. For instance, FreeMotion™ RT043 product launched by Fisher & Paykel Healthcare Limited offers several benefits. The under-chin seal provides for a comfortable and stable fit. The headgear system is designed for patient comfort and security, and anti-asphyxiation/non-rebreather valve included for safety in the event of flow source failure among other benefits.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Key Trends | Impact |
Rising Respiratory Diseases | An increase in respiratory illnesses, such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia, is propelling the demand for non-rebreathing oxygen masks worldwide. This increase is not just a medical issue but a growing public health concern. This is further heightened by aging populations and lifestyle factors such as smoking and exposure to pollutants. Geriatric population is more prone to respiratory diseases due to natural decline in immune system deficiency and lung function. |
COVID-19 Impact | The COVID-19 pandemic has shifted the respiratory care devices market, including the non-rebreathing masks. There has been a dual impact on the market. There was a surge in demand for critical care requirements of COVID-19 patients. Post-pandemic, the market observed benefit due to increased awareness and preparedness for respiratory infections. |
Increase in Surgical Procedures and Emergency Care | As healthcare standards around the world rises, more sophisticated surgical procedures are becoming common. Non-rebreathing masks are essential in pre- and post-operative care units. These masks offer high oxygen concentrations, which are crucial in emergencies involving respiratory distress or failure, ensuring rapid response capabilities, supporting their increased adoption. |
Technological Advancements | Innovations in medical devices are enhancing the effectiveness and comfort of non-rebreathing oxygen masks. Features such as reduced risk of CO2 retention, improved mask fit, development of softer, skin-friendly materials resulting in reduced discomfort and irritation during extended use, and enhanced oxygen delivery efficiency make these masks more appealing for both patients and healthcare providers. |
Market Breakup by Type
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Type is Anticipated to Witness Substantial Growth
Based on application, the market is segmented into paediatric and adult oxygen masks, each catering to different demographic needs. The adult segment is larger driven by the expansion in elder population and the increasing prevalence of chronic respiratory diseases such as asthma and COPD among adults. The paediatric segment is driven by the need for tailored oxygen delivery solutions in paediatric care.
Both the segments are anticipated to experience significant growth propelled by the increase in healthcare expenditure, increasing awareness regarding early and effective respiratory management, and advancements in oxygen therapy technologies. With the worldwide increase in pollution levels, the demand for respiratory aids increases, thereby propelling the non-rebreathing oxygen mask market share value.
Hospitals are Expected to Lead the Market Share
Based on end user, the market constitutes hospitals, specialty clinics, ambulatory surgical centers, home healthcare, trauma centers, and others. Hospitals hold the largest segment attributed to their critical role in delivering emergency care and the high volume of patients requiring respiratory support. Also, hospitals facilitate care for acute and chronic conditions requiring oxygen therapy, such as asthma, pneumonia, and COPD.
Specialty clinics caters to specific areas like pulmonary care, making them critical in the specialized treatment of respiratory disorders. The growth of specialty clinics is on the rise due to the preference for personalized care and targeted therapies, resulting in the adoption of advanced respiratory devices like non-rebreathing masks.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is the largest market due to its well-established healthcare infrastructure, a significant prevalence of respiratory diseases, and high healthcare expenditure. Europe holds significant market share with comparable drivers with an addition of strong regulatory framework and healthcare facilities.
Asia Pacific region is projected to grow at a faster rate during the forecast period. This growth is propelled by rising awareness of respiratory conditions, increasing healthcare investments, and improvements in healthcare infrastructure in densely inhabited countries like China and India. Moreover, the aging population and increasing air pollution in this region contribute to higher demands for respiratory care products and hence contribute to the market significantly.
The key features of the market report include strategic initiatives such as recent mergers, acquisitions and product launches by the key players. The major companies in the market are as follows:
Teleflex Incorporated
Teleflex Incorporated is a global provider of medical technologies designed to improve the health and quality of people's lives. The company's diverse portfolio includes products for vascular access, anesthesia, cardiac care, urology, respiratory care, and surgery, among other areas.
Medguard Healthcare
Medguard Healthcare is known for supplying high-quality medical devices and equipment, catering to the needs of healthcare professionals and facilities across various regions. The company emphasizes customer service, ensuring that healthcare providers have access to the necessary tools for effective patient care. Medguard's extensive product range supports a variety of medical disciplines.
Intersurgical Inc.
Intersurgical Inc. specializes in respiratory care products, offering innovative solutions for airway management, anesthesia, critical care, and oxygen therapy. The company is committed to improving patient outcomes through the development of high-quality, reliable medical devices.
Fisher & Paykel Healthcare Limited
Fisher & Paykel Healthcare Limited is a leading designer, manufacturer, and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea. It is renowned for its commitment to research and development, ensuring continuous advancement in medical technology.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Non-Rebreathing Oxygen Mask Market Overview
3.1 Global Non-Rebreathing Oxygen Mask Market Historical Value (2017-2023)
3.2 Global Non-Rebreathing Oxygen Mask Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Non-Rebreathing Oxygen Mask Market Landscape*
5.1 Global Non-rebreathing Oxygen Mask: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Non-rebreathing Oxygen Mask: Product Landscape
5.2.1 Analysis by Type
6 Global Non-Rebreathing Oxygen Mask Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Non-Rebreathing Oxygen Mask Market Segmentation (2017-2032)
7.1 Global Non-Rebreathing Oxygen Mask Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Paediatric Oxygen Mask
7.1.3 Adult Oxygen Mask
7.2 Global Non-Rebreathing Oxygen Mask Market (2017-2032) by End User
7.2.1 Market Overview
7.2.2 Hospitals
7.2.3 Specialty Clinics
7.2.4 Ambulatory Surgical Centres
7.2.5 Home Healthcare
7.2.6 Trauma Centres
7.2.7 Others
7.3 Global Non-Rebreathing Oxygen Mask Market (2017-2032) by Region
7.3.1 Market Overview
7.3.2 North America
7.3.3 Europe
7.3.4 Asia Pacific
7.3.5 Latin America
7.3.6 Middle East and Africa
8 North America Non-Rebreathing Oxygen Mask Market (2017-2032)
8.1 North America Non-Rebreathing Oxygen Mask Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Paediatric Oxygen Mask
8.1.3 Adult Oxygen Mask
8.2 North America Non-Rebreathing Oxygen Mask Market (2017-2032) by End User
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Specialty Clinics
8.2.4 Ambulatory Surgical Centres
8.2.5 Home Healthcare
8.2.6 Trauma Centres
8.2.7 Others
8.3 North America Non-Rebreathing Oxygen Mask Market (2017-2032) by Country
8.3.1 United States of America
8.3.2 Canada
9 Europe Non-Rebreathing Oxygen Mask Market (2017-2032)
9.1 Europe Non-Rebreathing Oxygen Mask Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Paediatric Oxygen Mask
9.1.3 Adult Oxygen Mask
9.2 Europe Non-Rebreathing Oxygen Mask Market (2017-2032) by End User
9.2.1 Market Overview
9.2.2 Hospitals
9.2.3 Specialty Clinics
9.2.4 Ambulatory Surgical Centres
9.2.5 Home Healthcare
9.2.6 Trauma Centres
9.2.7 Others
9.3 Europe Non-Rebreathing Oxygen Mask Market (2017-2032) by Country
9.3.1 United Kingdom
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Others
10 Asia Pacific Non-Rebreathing Oxygen Mask Market (2017-2032)
10.1 Asia Pacific Global Non-Rebreathing Oxygen Mask Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Paediatric Oxygen Mask
10.1.3 Adult Oxygen Mask
10.2 Asia Pacific Global Non-Rebreathing Oxygen Mask Market (2017-2032) by End User
10.2.1 Market Overview
10.2.2 Hospitals
10.2.3 Specialty Clinics
10.2.4 Ambulatory Surgical Centres
10.2.5 Home Healthcare
10.2.6 Trauma Centres
10.2.7 Others
10.3 Asia Pacific Non-Rebreathing Oxygen Mask Market (2017-2032) by Country
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 ASEAN
10.3.5 Australia
10.3.6 Others
11 Latin America Non-Rebreathing Oxygen Mask Market (2017-2032)
11.1 Latin America Non-Rebreathing Oxygen Mask Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Paediatric Oxygen Mask
11.1.3 Adult Oxygen Mask
11.2 Latin America Non-Rebreathing Oxygen Mask Market (2017-2032) by End User
11.2.1 Market Overview
11.2.2 Hospitals
11.2.3 Specialty Clinics
11.2.4 Ambulatory Surgical Centres
11.2.5 Home Healthcare
11.2.6 Trauma Centres
11.2.7 Others
11.3 Latin America Non-Rebreathing Oxygen Mask Market (2017-2032) by Country
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Mexico
11.3.4 Others
12 Middle East and Africa Non-Rebreathing Oxygen Mask Market (2017-2032)
12.1 Middle East and Africa Non-Rebreathing Oxygen Mask Market (2017-2032) by Type
12.1.1 Market Overview
12.1.2 Paediatric Oxygen Mask
12.1.3 Adult Oxygen Mask
12.2 Middle East and Africa Non-Rebreathing Oxygen Mask Market (2017-2032) by End User
12.2.1 Market Overview
12.2.2 Hospitals
12.2.3 Specialty Clinics
12.2.4 Ambulatory Surgical Centres
12.2.5 Home Healthcare
12.2.6 Trauma Centres
12.2.7 Others
12.3 Middle East and Africa Non-Rebreathing Oxygen Mask Market (2017-2032) by Country
12.3.1 Saudi Arabia
12.3.2 United Arab Emirates
12.3.3 Nigeria
12.3.4 South Africa
12.3.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Strategic Initiatives
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership and Collaborations
14.3 Analysis by Joint Ventures
14.4 Analysis by Leading Players
14.5 Analysis by Geography
15 Supplier Landscape
15.1 Market Share Analysis, By Region (Top 5 Companies)
15.1.1 Market Share Analysis: Global
15.1.2 Market Share Analysis: North America
15.1.3 Market Share Analysis: Europe
15.1.4 Market Share Analysis: Asia-Pacific
15.1.5 Market Share Analysis: Others
15.2 Teleflex Incorporated
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Medguard Healthcare
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Intersurgical Inc.
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Fisher & Paykel Healthcare Limited
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
16 Global Non-Rebreathing Oxygen Mask Market – Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.